| Global impact of COVID-19 on stroke care RG Nogueira, M Abdalkader, MM Qureshi, MR Frankel, OY Mansour, ... International journal of stroke 16 (5), 573-584, 2021 | 152 | 2021 |
| Global impact of COVID-19 on stroke care and IV thrombolysis RG Nogueira, MM Qureshi, M Abdalkader, SO Martins, H Yamagami, ... Neurology 96 (23), e2824-e2838, 2021 | 133 | 2021 |
| Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients S Rezapour-Firouzi, SR Arefhosseini, F Mehdi, EM Mehrangiz, ... Complementary therapies in medicine 21 (5), 473-480, 2013 | 84 | 2013 |
| The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial DS Oskouei, R Rikhtegar, M Hashemilar, H Sadeghi-Bazargani, ... Journal of Stroke and Cerebrovascular Diseases 22 (8), e557-e563, 2013 | 60 | 2013 |
| Diagnostic Value of Ultrasonography and Magnetic Resonance Imaging in Ulnar Neuropathy at the Elbow H Ayromlou, MK Tarzamni, MH Daghighi, MZ Pezeshki, M Yazdchi, ... ISRN Neurology 2012, 2012 | 57 | 2012 |
| Stroke subtypes, risk factors and mortality rate in northwest of Iran M Farhoudi, K Mehrvar, H Sadeghi-Bazargani, M Hashemilar, ... Iranian journal of neurology 16 (3), 112, 2017 | 40 | 2017 |
| Global impact of the COVID-19 pandemic on stroke volumes and cerebrovascular events: a 1-year follow-up TN Nguyen, MM Qureshi, P Klein, H Yamagami, R Mikulik, ... Neurology 100 (4), e408-e421, 2023 | 38 | 2023 |
| Efficacy of citalopram on acute ischemic stroke outcome: a randomized clinical trial D Savadi Oskouie, E Sharifipour, H Sadeghi Bazargani, M Hashemilar, ... Neurorehabilitation and Neural Repair 31 (7), 638-647, 2017 | 37 | 2017 |
| Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention S Rezapour-Firouzi, SR Arefhosseini, M Ebrahimi-Mamaghani, ... Complementary Therapies in Medicine 22 (6), 986-993, 2014 | 34 | 2014 |
| Allopurinol as a preventive contrivance after acute ischemic stroke in patients with a high level of serum uric acid: a randomized, controlled trial AA Taheraghdam, E Sharifipour, A Pashapour, S Namdar, A Hatami, ... Medical Principles and Practice 23 (2), 134-139, 2014 | 34 | 2014 |
| Simple In‐Hospital Interventions to Reduce Door‐to‐CT Time in Acute Stroke E Sadeghi-Hokmabadi, A Taheraghdam, M Hashemilar, R Rikhtegar, ... International journal of vascular medicine 2016 (1), 1656212, 2016 | 26 | 2016 |
| Effect of IMOD™ on the inflammatory process after acute ischemic stroke: a randomized clinical trial M Farhoudi, M Najafi-Nesheli, M Hashemilar, A Mahmoodpoor, ... DARU Journal of Pharmaceutical Sciences 21, 1-8, 2013 | 25 | 2013 |
| Safety and outcomes of intravenous thrombolytic therapy in ischemic stroke patients with COVID-19: CASCADE initiative P Sasanejad, LA Hezarkhani, S Arsang-Jang, G Tsivgoulis, A Ghoreishi, ... Journal of stroke and cerebrovascular diseases 30 (12), 106121, 2021 | 24 | 2021 |
| Eligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementation H Ayromlou, H Soleimanpour, M Farhoudi, A Taheraghdam, ... Iranian Red Crescent Medical Journal 16 (5), 2014 | 24 | 2014 |
| Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in … S Rezapour-Firouzi, SR Arefhosseini, M Ebrahimi-Mamaghani, ... Complementary therapies in medicine 23 (5), 652-657, 2015 | 23 | 2015 |
| Electrical interferential current stimulation versus electrical acupuncture in management of hemiplegic shoulder pain and disability following ischemic stroke-a randomized … F Eslamian, M Farhoudi, F Jahanjoo, E Sadeghi-Hokmabadi, P Darabi Archives of Physiotherapy 10, 1-12, 2020 | 22 | 2020 |
| Effect of whey protein supplementation on inflammatory and antioxidant markers, and clinical prognosis in acute ischemic stroke (TNS Trial): a randomized, double blind … M Hashemilar, M Khalili, N Rezaeimanesh, ES Hokmabadi, S Rasulzade, ... Advanced pharmaceutical bulletin 10 (1), 135, 2020 | 20 | 2020 |
| What are the most important barriers for thrombolytic therapy in ischemic stroke patients? H Ayromlou, H Soleimanpour, M Farhoudi, E Sadeghi‐Hokmabadi, ... International Journal of Stroke 8 (4), E7-E7, 2013 | 20 | 2013 |
| Public knowledge of people visiting Imam Reza hospital regarding stroke symptoms and risk factors E Sadeghi-Hokmabadi, SS Vahdati, R Rikhtegar, K Ghasempour, ... BMC emergency medicine 19, 1-5, 2019 | 19 | 2019 |
| Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study E Sadeghi-Hokmabadi, M Farhoudi, A Taheraghdam, M Hashemilar, ... International journal of general medicine, 361-367, 2016 | 18 | 2016 |
Mehdi FarhoudiProfessor of Neurology, Fellowship of Stroke, Neurosciences Research Center, World Stroke Board在 tbzmed.ac.ir 的电子邮件经过验证
